53 completed, 25 unknown, 23 recruiting, 10 terminated. 43 Phase 2, 28 Not applicable, 20 Phase 1, 12 Phase 3, 2 Phase 4.
Follow Stomach Cancer: new trials by email Literature Review of Stomach Cancer trials Research Report on Stomach Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| TRANScriptional Pathways Of Surgical Pain Modulated by Music Therapy Exposure (TRANSPOSE) Music-assisted relaxation and imagery (MARI) - Surgery, Stomach Cancer | Not applicable | Not yet recruiting | Case Comprehensive Cancer Center | 20 | 2027-01-01 | 2026-08-05 |
| Zanidatamab Outcomes and Lived Experiences in Advanced HER2+ GEA Zanidatamab - Esophageal Cancer, GastroEsophageal Cancer | Not yet recruiting | Jazz Pharmaceuticals | 300 | 2026-11-30 | 2026-10-26 | |
| Multimodal Liquid-Biopsy Omics Biomarkers of Treatment Response in Breast Cancer Lung Cancer Non-small Cell, Colorectal Cancer | Not yet recruiting | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2000 | 2026-10-01 | 2026-10-19 | |
| The Application of 18F-G1 PET/CT Targeting Granzyme B in the Pan-cancer Immunotherapy 18F-G1 - Solid Tumor Malignancies, Hematologic Cancer | Recruiting | Peking University First Hospital | 120 | 2026-09-08 | 2026-09-28 | |
| A Phase 1 Study of IM-1617 in Participants With Advanced Cancer IM-1617 - Colorectal Cancer, Non-Small Cell Lung Cancer | Phase 1 | Recruiting | Immunome, Inc. | 175 | 2026-05-21 | 2026-09-29 |
| The Effect of Stress Ball on Nausea, Anxiety, and Fatigue in Patients With Stomach Cancer A device/tool called a stress ball - Stomach Cancer, Chemotherapy-induced Nausea and Vomiting | Not applicable | Completed | Yuzuncu Yil University | 52 | 2026-03-20 | 2026-07-07 |
| Cancer Loyalty Card Study 2 (CLOCS-2) Cases & Controls - Pancreatic Cancer, Colon Cancer | Recruiting | Imperial College London | 2900 | 2026-02-04 | 2026-03-25 | |
| A First-in-human Study of 3H-10000 in Patients With Unresectable or Metastatic Solid Tumors 3H-10000 - Lung Cancer, Stomach Cancer | Phase 1 / Phase 2 | Recruiting | 3H Pharmaceuticals Co., Ltd. | 170 | 2026-01-04 | 2026-01-21 |
| Large Language Models Assist in Tumor MDT LLM assists in MDT report writing - Lung Cancer, Breast Cancer | Not applicable | Recruiting | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 60 | 2026-01-01 | 2026-03-31 |
| Robotic Gastrectomy With 5th Arm Robotic gastrectomy performed with Cornerstone Robotics Sentire Surgical System C1000 Ultra (With Patient Side Single Arm) - Stomach Cancer | Not applicable | Recruiting | Chinese University of Hong Kong | 10 | 2025-12-31 | 2025-12-30 |
| Evaluation of the NEOmom® Gastric Video Capsule for Gastric Cancer Screening Magnetically controlled video capsule endoscopy (MC-VCE) - Stomach Cancer, Diagnosis | Not applicable | Not yet recruiting | Nantes University Hospital | 100 | 2025-12-15 | 2026-01-07 |
| Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA Ivonescimab, 5-Fluorouracil, Oxaliplatin - Stomach Cancer Stage IV, Esophagus Cancer | Phase 2 | Recruiting | Massachusetts General Hospital | 40 | 2025-10-10 | 2026-08-28 |
| Total Neoadjuvant FLOT Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer Docetaxel, Oxaliplatin, Leucovorin - Gastric Cancer, Stomach Cancer | Phase 2 / Phase 3 | Recruiting | Ukrainian Society of Clinical Oncology | 150 | 2025-03-25 | 2025-05-06 |
| Brodalumab in the Treatment of Immune-Related Adverse Events Brodalumab, CT scan - Breast Cancer, Esophageal Cancer | Phase 1 | Recruiting | Brian Henick, MD | 11 | 2025-03-11 | 2026-05-13 |
| Target-specific immunoPET Imaging of Digestive System Carcinoma [68Ga]Ga-DOTA-H2D3, [18F]F-RESCA-RB14, [68Ga]Ga-NOTA-T4 - Malignancy, Digestive Cancer | Not applicable | Recruiting | RenJi Hospital | 400 | 2024-12-04 | 2025-12-31 |
| EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer. EQUITY GI - Gastrointestinal Cancer, Colon Cancer | Not applicable | Recruiting | Case Comprehensive Cancer Center | 200 | 2024-12-01 | 2026-09-15 |
| Avutometinib and Defactinib in Diffuse Gastric Cancer Avutometinib, Defactinib - Gastric Cancer, Stomach Cancer | Phase 2 | Recruiting | Ryan H. Moy, MD, PhD | 27 | 2024-10-28 | 2025-11-04 |
| Enhanced Assistance During Radiotherapy for Unmet Essential Needs Standard assistance, Enhanced assistance - Bone Cancer, Brain Cancer | Not applicable | Completed | Washington University School of Medicine | 33 | 2024-10-04 | 2025-08-26 |
| TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Stomach and Esophageal Cancer Tumor Infiltrating Lymphocytes (TIL), Cyclophosphamid, Fludarabine - Stomach Cancer, Stomach Cancer Recurrent | Phase 1 / Phase 2 | Recruiting | Essen Biotech | 75 | 2024-09-10 | 2024-11-12 |
| Study of CEA Targeting CAR-T (PTC13) in the Treatment of CEA-Positive Advanced Malignant Solid Tumors Intraperitoneal infusion of FAST CEA-targeted CAR-T - Colorectal Cancer, Stomach Cancer | Phase 1 | Recruiting | Weijia Fang, MD | 18 | 2024-07-24 | 2026-01-23 |
Showing 20 of 125. Sign in to see all of them.
Stomach Neoplasms (125) · Esophageal Neoplasms (45) · Pancreatic Neoplasms (27) · Lung Neoplasms (24) · Breast Neoplasms (21) · Colorectal Neoplasms (19) · Liver Neoplasms (19) · Colonic Neoplasms (15) · Ovarian Neoplasms (14) · Neoplasms (11) · Gastrointestinal Neoplasms (10) · Kidney Neoplasms (9) · Gallbladder Neoplasms (8) · Rectal Neoplasms (8) · Urinary Bladder Neoplasms (8)
Neoplasms by Site (125) · Stomach Diseases (125) · Digestive System Diseases (124) · Gastrointestinal Diseases (124) · Digestive System Neoplasms (123) · Gastrointestinal Neoplasms (115) · Neoplasms (114) · Esophageal Diseases (45) · Head and Neck Neoplasms (41) · Endocrine Gland Neoplasms (36) · Endocrine System Diseases (36) · Intestinal Diseases (36) · Intestinal Neoplasms (34) · Colonic Diseases (32) · Lung Diseases (29)
Oxaliplatin (14) · Docetaxel (10) · Capecitabine (8) · Paclitaxel (8) · Cisplatin (7) · Fluorouracil (7) · Irinotecan (7) · pembrolizumab (6) · Leucovorin (5) · Ramucirumab (5) · Mitomycin (4) · S 1 (combination) (4) · Trastuzumab (4) · Bevacizumab (3) · Surgical Procedures, Operative (3)
National Cancer Institute (NCI) (5) · Asan Medical Center (4) · Dana-Farber Cancer Institute (4) · Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest (4) · Yonsei University (4) · NYU Langone Health (3) · Washington University School of Medicine (3) · Bristol-Myers Squibb (2) · Case Comprehensive Cancer Center (2) · Gangnam Severance Hospital (2) · National Cancer Center, Korea (2) · Samsung Medical Center (2) · Seoul National University Bundang Hospital (2) · Stanford University (2) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (2)
United States (44) · China (25) · South Korea (21) · Germany (6) · France (4) · Italy (3) · Japan (3) · Australia (2) · Brazil (2) · Canada (2) · Hong Kong (2) · Portugal (2) · Puerto Rico (2) · Singapore (2) · Spain (2)
Salah-Eddin Al-Batran, Prof. Dr. (3) · Andrew M Blakely, M.D. (2) · Yoon-Koo Kang, M.D.,Ph.D. (2) · Ahmet Seker, MD (1) · Akos Czibere, MD, PhD (1) · Alisa M Goldstein, Ph.D. (1) · Amit Mahipal, MBBS (1) · Anders Johnsson, MD, PhD (1) · Andrey Ryabov, MD, PhD (1) · Arndt Vogel, Prof. (1) · Arndt Vogel, Prof. Dr. (1) · Asim Shabbir, MBBS (1) · Birendra K Sah, PH D (1)
PMID 35623069, PMID 15239282, PMID 16240061, PMID 18071862, PMID 20354452, PMID 22479375, PMID 24380989, PMID 25287828, PMID 27765757, PMID 29149611, PMID 29332445, PMID 30027782, PMID 30036892, PMID 31060836, PMID 31595970, PMID 32653053, PMID 33435909, PMID 34172290, PMID 35709415, PMID 35817563, PMID 36776716, PMID 36883420, PMID 36950857, PMID 37036671, PMID 37104758, PMID 37707375, PMID 37903316, PMID 38022553, PMID 38191613, PMID 38829053, PMID 38954929, PMID 40315882, PMID 40541392, PMID 40673842, PMID 41853923, PMID 42128509
2018 (1), K01AT008219 (1), P30CA068485 (1), R01CA252211 (1)